Dimethyl Sulfoxide Induces Both Direct and Indirect Tau Hyperphosphorylation

Dimethyl sulfoxide (DMSO) is widely used as a solvent or vehicle for biological studies, and for treatment of specific disorders, including traumatic brain injury and several forms of amyloidosis. As Alzheimer’s disease (AD) brains are characterized by deposits of β-amyloid peptides, it has been suggested that DMSO could be used as a treatment for this devastating disease. AD brains are also characterized by aggregates of hyperphosphorylated tau protein, but the effect of DMSO on tau phosphorylation is unknown. We thus investigated the impact of DMSO on tau phosphorylation in vitro and in vivo. One hour following intraperitoneal administration of 1 or 2 ml/kg DMSO in mice, no change was observed in tau phosphorylation. However, at 4 ml/kg, tau was hyperphosphorylated at AT8 (Ser202/Thr205), PHF-1 (Ser396/Ser404) and AT180 (Thr231) epitopes. At this dose, we also noticed that the animals were hypothermic. When the mice were maintained normothermic, the effect of 4 ml/kg DMSO on tau hyperphosphorylation was prevented. On the other hand, in SH-SY5Y cells, 0.1% DMSO induced tau hyperphosphorylation at AT8 and AT180 phosphoepitopes in normothermic conditions. Globally, these findings demonstrate that DMSO can induce tau hyperphosphorylation indirectly via hypothermia in vivo, and directly in vitro. These data should caution researchers working with DMSO as it can induce artifactual results both in vivo and in vitro.

[1]  M. Menger,et al.  Heme oxygenase (HO)-1 protects from lipopolysaccharide (LPS)-mediated liver injury by inhibition of hepatic leukocyte accumulation and improvement of microvascular perfusion , 2010, Langenbeck's Archives of Surgery.

[2]  I. Tetko,et al.  In silico approaches to prediction of aqueous and DMSO solubility of drug-like compounds: trends, problems and solutions. , 2006, Current medicinal chemistry.

[3]  F. Sun,et al.  Dynamic changes of phosphorylated tau in mouse hippocampus after cold water stress , 2005, Neuroscience Letters.

[4]  J. Farrant.  Pharmacological actions and toxicity of dimethyl sulphoxide and other compounds which protect smooth muscle during freezing and thawing , 1964, The Journal of pharmacy and pharmacology.

[5]  S. Foster,et al.  GSK-3β inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat* , 2005, Critical care medicine.

[6]  Akihiko Takashima,et al.  Alterations in Glucose Metabolism Induce Hypothermia Leading to Tau Hyperphosphorylation through Differential Inhibition of Kinase and Phosphatase Activities: Implications for Alzheimer's Disease , 2004, The Journal of Neuroscience.

[7]  F. LaFerla,et al.  Nicotinamide Restores Cognition in Alzheimer's Disease Transgenic Mice via a Mechanism Involving Sirtuin Inhibition and Selective Reduction of Thr231-Phosphotau , 2008, The Journal of Neuroscience.

[8]  A. Delacourte,et al.  p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death , 2005, Journal of Cell Science.

[9]  B. Fiebich,et al.  Pharmacological inhibition of Akt and downstream pathways modulates the expression of COX-2 and mPGES-1 in activated microglia , 2012, Journal of Neuroinflammation.

[10]  E. Planel,et al.  Hypothermia and Alzheimer's disease neuropathogenic pathways. , 2010, Current Alzheimer research.

[11]  C. Richter-Landsberg,et al.  Activation of PP2A‐like phosphatase and modulation of tau phosphorylation accompany stress‐induced apoptosis in cultured oligodendrocytes , 2002, Glia.

[12]  E. Mandelkow,et al.  The switch of tau protein to an Alzheimer‐like state includes the phosphorylation of two serine‐proline motifs upstream of the microtubule binding region. , 1992, The EMBO journal.

[13]  Ralf Hoffmann,et al.  Epitope mapping of mAbs AT8 and Tau5 directed against hyperphosphorylated regions of the human tau protein. , 2007, Biochemical and biophysical research communications.

[14]  D. Wood,et al.  PHARMACOLOGIC AND BIOCHEMICAL CONSIDERATIONS OF DIMETHYL SULFOXIDE , 1975, Annals of the New York Academy of Sciences.

[15]  A. Delacourte,et al.  Mitotic-like Tau Phosphorylation by p25-Cdk5 Kinase Complex* , 2003, Journal of Biological Chemistry.

[16]  A. Delacourte,et al.  Pathological Tau Phenotypes: The Weight of Mutations, Polymorphisms, and Differential Neuronal Vulnerabilities , 2000, Annals of the New York Academy of Sciences.

[17]  L. Virág,et al.  Propofol Directly Increases Tau Phosphorylation , 2011, PloS one.

[18]  Brian J Cummings,et al.  Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites. , 1994, Neuroreport.

[19]  D. Dickson,et al.  Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  J. C. de la Torre,et al.  Pharmacology of dimethyl sulfoxide in cardiac and CNS damage , 2009, Pharmacological reports : PR.

[21]  S. Fujita,et al.  Stress‐induced hyperphosphorylation of tau in the mouse brain , 2003, FEBS letters.

[22]  E. Vanmechelen,et al.  Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205 , 1995, Neuroscience Letters.

[23]  E. Barea-Rodriguez,et al.  ERK phosphorylation is required for retention of trace fear memory , 2006, Neurobiology of Learning and Memory.

[24]  M. Salcman,et al.  Morphologic effect of dimethyl sulfoxide on the blood-brain barrier. , 1982, Science.

[25]  M. Ashwood‐Smith.  RADIOPROTECTIVE AND CRYOPROTECTIVE PROPERTIES OF DIMETHYL SULFOXIDE IN CELLULAR SYSTEMS , 1967, Annals of the New York Academy of Sciences.

[26]  M. Leist,et al.  Efficacy of small‐molecule glycogen synthase kinase‐3 inhibitors in the postnatal rat model of tau hyperphosphorylation , 2007, British journal of pharmacology.

[27]  H. Bouyssou,et al.  [TOXICITY AND PHARMACOLOGICAL APTITUDES OF DIMETHYLSULFOXIDE]. , 1964, Comptes rendus hebdomadaires des seances de l'Academie des sciences.

[28]  R. Nelson,et al.  Anesthesia Leads to Tau Hyperphosphorylation through Inhibition of Phosphatase Activity by Hypothermia , 2007, The Journal of Neuroscience.

[29]  J. Luchsinger,et al.  Insulin Dysfunction Induces In Vivo Tau Hyperphosphorylation through Distinct Mechanisms , 2007, The Journal of Neuroscience.

[30]  M. Goedert,et al.  Monoclonal antibody PHF‐1 recognizes tau protein phosphorylated at serine residues 396 and 404 , 1994, Journal of neuroscience research.

[31]  B. Chen,et al.  Experimental study on genistein prevention and treatment of transplant arteriosclerosis in aortic transplants of rat. , 2006, Transplantation proceedings.

[32]  Jianhua Shi,et al.  PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta. , 2010, Journal of Alzheimer's disease : JAD.

[33]  J. Lovelock,et al.  Prevention of Freezing Damage to Living Cells by Dimethyl Sulphoxide , 1959, Nature.

[34]  M. Hayashi,et al.  Evaluation of absorbability of poorly water-soluble drugs: validity of the use of additives. , 2000, Biological & pharmaceutical bulletin.

[35]  Kirk W. Johnson,et al.  Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. , 2003, Diabetes.

[36]  A. Delacourte,et al.  Abnormal Tau phosphorylation of the Alzheimer‐type also occurs during mitosis , 2002, Journal of neurochemistry.

[37]  I. Grundke‐Iqbal,et al.  Restoration of biological activity of Alzheimer abnormally phosphorylated tau by dephosphorylation with protein phosphatase-2A, -2B and -1. , 1996, Brain research. Molecular brain research.

[38]  L. Binder,et al.  Rapid reversible phosphorylation of rat brain tau proteins in response to cold water stress , 1995, Neuroscience Letters.

[39]  S. Fujita,et al.  Inhibition of Protein Phosphatase 2A Overrides Tau Protein Kinase I/Glycogen Synthase Kinase 3β and Cyclin-dependent Kinase 5 Inhibition and Results in Tau Hyperphosphorylation in the Hippocampus of Starved Mouse* , 2001, The Journal of Biological Chemistry.

[40]  P. Cohen,et al.  Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. , 1994, The Biochemical journal.

[41]  Martin L Yarmush,et al.  Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure , 2012, Nature Biotechnology.

[42]  Carlota Saldanha,et al.  Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. , 2003, Biochemical pharmacology.

[43]  S. Hellberg,et al.  A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation. , 2009, The Journal of clinical investigation.

[44]  Manuela G. López,et al.  The antinociceptive effects of AR-A014418, a selective inhibitor of glycogen synthase kinase-3 beta, in mice. , 2011, The journal of pain : official journal of the American Pain Society.

[45]  S. Harkins,et al.  “Amyloid Is Not a Tombstone”— A Summation , 1997, Annals of the New York Academy of Sciences.

[46]  P. Cohen,et al.  p42 map kinase phosphorylation sites in microtubule‐associated protein tau are dephosphorylated by protein phosphatase 2A1 Implications for Alzheimer's disease , 1992, FEBS letters.

[47]  L. Poellinger,et al.  Comparison of acute toxicities of indolo[3,2-b]carbazole (ICZ) and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive rats. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.